Clinical Trials Logo
  1. Home
  2. Spinocerebellar Ataxias
  3. NCT02960893

Trial in Adult Subjects With Spinocerebellar Ataxia

Spinocerebellar Ataxias Clinical Trial

Official title:
A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult Subjects With Spinocerebellar Ataxia

Clinical Trial Summary

The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA).

Clinical Trial Description

The study was conducted in 2 phases: Randomization Phase (8 weeks) followed by an open-label Extension Phase (48 weeks). During the Randomization Phase, participants received either Troriluzole 140 mg or matching placebo up to 8 weeks. Participants who agreed to enter the Extension Phase continued dosing of Troriluzole 140 mg for 48 weeks. The study was subsequently amended to follow participants for a total of 192 weeks in the Extension Phase. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02960893
Study type Interventional
Source Biohaven Pharmaceuticals, Inc.
Contact
Status Active, not recruiting
Phase Phase 2/Phase 3
Start date December 15, 2016
Completion date September 23, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05973019 - rTMS Improves Functions in Spinocerebellar Ataxia N/A
Completed NCT04837027 - Effect of Training on Brain Volume in Ataxia N/A
Completed NCT04595578 - Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia N/A
Completed NCT03745248 - Aerobic Exercise, Balance Training, and Ataxia N/A
Completed NCT05951010 - Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38 N/A
Completed NCT01037777 - RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Completed NCT00136630 - Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Completed NCT03687190 - Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients N/A
Active, not recruiting NCT03701399 - Troriluzole in Adult Subjects With Spinocerebellar Ataxia Phase 3
Completed NCT05436262 - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia N/A
Recruiting NCT04231487 - Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Withdrawn NCT04301284 - Study of CAD-1883 for Spinocerebellar Ataxia Phase 2
Not yet recruiting NCT06177626 - Impact of Exercise on Eyeblink Conditioning in Spinocerebellar Ataxias N/A
Recruiting NCT04529252 - Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Completed NCT05621200 - Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia N/A
Completed NCT03701776 - Ataxia and Exercise Disease Using MRI and Gait Analysis N/A
Completed NCT03120013 - Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia N/A
Active, not recruiting NCT03408080 - Open Pilot Trial of BHV-4157 Phase 3
Completed NCT04153110 - Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia N/A
Recruiting NCT05034172 - Biomarker Research in Inherited Movement Disorders